Genetic Technologies Limited

GENE · NASDAQ
Analyze with AI
6/30/2024
12/31/2023
6/30/2023
12/31/2022
Assets
Cash & Equivalents$1,021$3,729$7,851$5,045
Short-Term Investments$0$0$17$0
Receivables$2,127$1,115$192$2,931
Inventory$206$397$326$405
Other Curr. Assets$19$474$1,730$424
Total Curr. Assets$3,695$5,716$10,498$8,805
Property Plant & Equip (Net)$264$429$599$785
Goodwill$1,785$1,785$3,117$5,479
Intangibles$360$436$520$551
Long-Term Investments$0-$436$4,115$6,815
Tax Assets$82$101$122$74
Other NC Assets$0$436-$4,237-$6,815
Total NC Assets$2,491$2,751$4,237$6,890
Other Assets$0$0$122$0
Total Assets$6,187$8,467$14,856$15,695
Liabilities
Payables$1,458$1,917$838$2,474
Short-Term Debt$644$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$742$764$849$1,053
Other Curr. Liab.$571$0$779$0
Total Curr. Liab.$4,195$3,422$3,312$4,233
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$82$101$122$74
Other NC Liab.$56$48$30$30
Total NC Liab.$161$233$382$433
Other Liabilities$0$0$0$0
Cap. Leases$232$84$229$612
Total Liabilities$4,356$3,655$3,694$4,666
Equity
Pref Stock$0$0$0$0
Common Stock$163,818$161,343$161,343$155,139
Retained Earnings-$166,376-$160,778-$156,716-$155,667
AOCI$4,389$4,248$6,536$11,557
Other Equity$0$0$0$0
Total Equity$1,830$4,812$11,163$11,029
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$6,187$8,467$14,856$15,695
Net Debt-$377-$3,729-$7,851-$5,045